Nasal Drug Delivery Technology Market is Projected to Grow at a CAGR of 7.5% by 2033: Visiongain
June 14, 2023 06:00 ET
|
Visiongain Reports Ltd
As per the report by Visiongain, the Nasal Drug Delivery Technology Market was valued at US$71.0 billion in 2022 and is projected to grow at a CAGR of 7.5% during the forecast period 2023-2033. ...
Menopause Market is projected to grow at a CAGR of 5.4% by 2033: Visiongain
May 23, 2023 06:53 ET
|
Visiongain Reports Ltd
As per the report by Visiongain, the Menopause Market was valued at US$17.33 million in 2023 and is projected to grow at a CAGR of 5.4% during the forecast period 2023-2033. Visiongain has...
Nasal Drug Delivery Technology Market is Projected to Grow at a CAGR of 7.5% by 2033: Visiongain Reports Ltd
May 04, 2023 12:22 ET
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Nasal Drug Delivery Technology 2023-2033: Forecasts by Containers (Pressurized Containers, Non-pressurized Containers), by System (Nasal Bi Dose, Nasal...
Nasal Drug Delivery Technology Market is Projected to Grow at a CAGR of 7.5% by 2033: Visiongain Reports Ltd
April 19, 2023 11:58 ET
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Nasal Drug Delivery Technology 2023-2033: Forecasts by Containers (Pressurized Containers, Non-pressurized Containers), by System (Nasal Bi Dose, Nasal...
Gynaecology Drugs market is projected to grow at a CAGR of 5.1% by 2033: Visiongain Reports Ltd
April 13, 2023 06:00 ET
|
Visiongain Reports Ltd
Visiongain has published a new report: Gynaecology Drugs Market, (COVID-19 Impact Analysis):- Market Segment by Disease (Gynaecology Cancers, Contraception, Female Infertility, Menopausal Disorders,...
Gynaecology Drugs market is projected to grow at a CAGR of 5.1% by 2033: Visiongain Reports Ltd
March 15, 2023 10:00 ET
|
Visiongain Reports Ltd
Visiongain has published a new report: Gynaecology Drugs Market, (COVID-19 Impact Analysis):- Market Segment by Disease (Gynaecology Cancers, Contraception, Female Infertility, Menopausal Disorders,...
Meningococcal vaccines market is projected to grow at a CAGR of 6.32% by 2033: Visiongain Reports Ltd
February 28, 2023 09:20 ET
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Meningococcal Vaccines 2023-2033. It includes profiles of Meningococcal Vaccines and Forecasts Market Segment by Vaccine Type (Conjugate,...
Gynaecology Drugs market is projected to grow at a CAGR of 5.1% by 2033: Visiongain Reports Ltd
February 13, 2023 11:13 ET
|
Visiongain Reports Ltd
Visiongain has published a new report: Gynaecology Drugs Market, (COVID-19 Impact Analysis):- Market Segment by Disease (Gynaecology Cancers, Contraception, Female Infertility, Menopausal Disorders,...
Global mRNA Vaccines & Therapeutics market is projected to decline at a CAGR of -7.89% by 2032: Visiongain Reports Ltd
August 30, 2022 07:26 ET
|
Visiongain Reports Ltd
Market Segment by Type (mRNA Prophylactic Vaccines, Therapeutics Vaccines, mRNA Therapeutics), Market Segment by Vector (Self-amplifying, Non-amplifying mRNA), Market Segment by Vector Platforms...
Global Rare Disease Market Research Report Up to 2031: Visiongain Research Inc
April 13, 2022 11:00 ET
|
Visiongain Ltd
Visiongain has published a new report on “Rare Disease Market Forecast 2021-2031: By Drugs (Revlimid, MabThera/Rituxan, Opdivo, Imbruvica, Sprycel, Tasigna, Copaxone,Rebif, Gleevec, Velcade, Others),...